alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion. - Wikidata - wikimedia - TriplyDB

alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.

alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.

http://www.wikidata.org/entity/Q37387512

about

Design and synthesis of chroman derivatives with dual anti-breast cancer and antiepileptic activities.α-Tocopheryl Succinate Inhibits Osteolytic Bone Metastasis of Breast Cancer by Suppressing Migration of Cancer Cells and Receptor Activator of Nuclear Factor-κB Ligand Expression of Osteoblasts.

P2860

Q37241899-E8D235C0-F096-4BE3-8FEE-3AE027F5432C Q55118190-1A265E0E-770E-4656-BA29-AF4A7A25E6B0

P2860

alpha-Tocopheryl succinate as a scaffold to develop potent inhibitors of breast cancer cell adhesion.

http://www.wikidata.org/entity/Q37387512

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

alpha-Tocopheryl succinate as ...... f breast cancer cell adhesion.

@en

alpha-Tocopheryl succinate as ...... f breast cancer cell adhesion.

@nl

type

label

alpha-Tocopheryl succinate as ...... f breast cancer cell adhesion.

@en

alpha-Tocopheryl succinate as ...... f breast cancer cell adhesion.

@nl

prefLabel

alpha-Tocopheryl succinate as ...... f breast cancer cell adhesion.

@en

alpha-Tocopheryl succinate as ...... f breast cancer cell adhesion.

@nl

P1433

Q37387512-E853BFF6-38CF-4C87-83AD-74BCEC6B1722

P1476

Q37387512-F4CD5BF2-1111-417B-9B10-BCCFEF1E2094

P2093

Q37387512-27F0FC98-C0CE-49AC-A175-1B229FC17079

Q37387512-34CDD857-104F-408F-B176-50926C551D88

Q37387512-3DB2DB5B-3D68-4742-8D03-C05E1939740E

Q37387512-671C2ADD-F0C6-4AEB-8795-7CFD0E7F355B

Q37387512-9DA8EB0F-51BF-4801-9191-2C99E1EE0AAF

Q37387512-E754FEA6-438C-4B39-8037-4456821AE1AF

Q37387512-FEE05F4F-81D4-4A4C-A9AF-A3BE5571B308

P2860

Q37387512-02FC2BCB-9C18-4A5F-9CE2-95CB8FBA687C

Q37387512-28CCE7F8-1B3D-4DA7-9195-F48BBC5CD53A

Q37387512-2AD56CB4-84A7-4D84-A28F-AF2DAE8A0CF2

Q37387512-2EF3AB52-AF02-48D7-9F89-237FCEDDC5C6

Q37387512-304C9247-C81F-474B-B793-1EB723B6E813

Q37387512-3D279299-6720-4433-9209-26DA889CA8A3

Q37387512-56948848-8653-4E1C-AB26-D347CE6D7F2F

Q37387512-5D7E43EB-2C0A-4A6A-924A-5725FD9C6D51

Q37387512-76002640-1D50-46BD-8208-63A4CCE94514

Q37387512-81B39538-FF5F-41A9-9EC2-ADDDB658D68E

P304

Q37387512-7EDD9C00-B735-4E2D-8EF7-43811F1DE4EC

P31

Q37387512-7AB379E0-22ED-408C-8CDE-D08A41738092

P356

Q37387512-80209990-E98D-49C3-AAA7-B30E31593A25

P407

Q37387512-09DE205B-00D0-4797-9A99-D9CED1F5B93B

P433

Q37387512-87235362-492C-4D75-A536-B2EB2E428327

P478

Q37387512-D0D08835-C961-4412-A399-D76BC4C7D80E

P577

Q37387512-0AAE4625-C4E5-41AD-A582-266182C71DF3

P5875

Q37387512-C5C15B11-C2E2-470C-9CE6-C9F965002E0D

P698

Q37387512-6EB2F26E-4B5C-4CDD-B6DD-7A4BBD360824

P932

Q37387512-5B81F424-201E-4F54-986C-DD4DF89B2068

P356

P1433

Journal of Medicinal Chemistry

P1476

alpha-Tocopheryl succinate as ...... f breast cancer cell adhesion.

@en

P2093

Ching-Shih Chen

http://www.w3.org/2001/XMLSchema#string

Dasheng Wang

http://www.w3.org/2001/XMLSchema#string

Hao-Yu Hsieh

http://www.w3.org/2001/XMLSchema#string

Hsiao-Ching Chuang

http://www.w3.org/2001/XMLSchema#string

Po-Hsien Huang

http://www.w3.org/2001/XMLSchema#string

Samuel K Kulp

http://www.w3.org/2001/XMLSchema#string

Shu-Chuan Weng

http://www.w3.org/2001/XMLSchema#string

P2860

Integrin-regulated FAK-Src signaling in normal and cancer cells

Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271

Focal adhesion kinase: in command and control of cell motility

Cancer metastasis: building a framework

Imagable 4T1 model for the study of late stage breast cancer.

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma.

Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate.

Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease.

Anti-adhesion therapies.

The role of focal-adhesion kinase in cancer - a new therapeutic opportunity.

P304

5642-5648

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JM9002457

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26768700

http://www.w3.org/2001/XMLSchema#string

P698

19708661

http://www.w3.org/2001/XMLSchema#string

P932

2761948

http://www.w3.org/2001/XMLSchema#string